Physician profile
David Kirk Depriest
NPI 1285633313
$2,148.34
in general payments reported to CMS, 2019-2025
12 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $87.05 · 2021: $17.36 · 2022: $92.53 · 2023: $35.10 · 2024: $1,450 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,028 · Food and Beverage: $683 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,028.23 |
| Food and Beverage | $682.73 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,446.80 | 2020-2024 | |
| Sanara Medtech INC. | $206.70 | 2025 | Celleraterx |
| Leica Microsystems INC. | $135.96 | 2019 | |
| Mentor Worldwide LLC | $120.57 | 2019-2020 | |
| Smith+Nephew, INC. | $82.57 | 2019-2023 | Pico, Renasys Go V2 Home, Collagenase Santyl |
| Conmed Corporation | $62.50 | 2022 | |
| Merit Medical Systems INC | $28.06 | 2025 | Savi Scout |
| Braintree Laboratories, INC. | $17.36 | 2021 | |
| Allergan, INC. | $16.06 | 2022 | |
| Polynovo North America LLC | $15.99 | 2024 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $13.97 | 2022 | |
| Ethicon US, LLC | $1.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Depriest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.